Council of Scientific and Industrial Research (CSIR), under its New Millennium Indian Technology Leadership Initiative (NMITLI), has approved the implementation of customized adaptation of nonClonableID technology to establish authenticity of medical products. Dr. Praful Naik, executive director and chief scientific officer of Bilcare Ltd., has been designated principal investigator for the project.
 
The CSIR-NMITLI-Bilcare team will work to demonstrate the ability of a new nonClonableID technology to address the unmet needs in medical product authentication and patient safety. The nonClonableID technology is based on novel aspects of material science and uses the law of randomness to create unique non-duplicable fingerprints. These fingerprints when processed, digitized and activated can function as unique identification tags. The key objectives of the CSIR-NMITLI project is to demonstrate the utility of the nonClonableID tags in establishing product accountability through secured traceability from the point of origin to the point of dispensation, authenticity check and establishing e-pedigree.